Tessera Therapeutics is a biotechnology company pioneering Gene Writing™ technology to make permanent alterations to the human genome, aiming to cure diseases and advance genome engineering.
Remote
Georgia
Workers Affected
1
Notice Date
February 5, 2026
March 8, 2026
Unavailable
Permanent
Layoff
More WARN Notices from
